CLARIVATE PLC
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $CLVT in the last 30 days.
See all $CLVT insider activity →Wandercraft acquired Ekso Bionics to form a global medical exoskeleton company. Automation Anywhere agreed to buy Boost.ai for conversational AI. Beam Global will acquire ScoutDI for $24M to expand drone tech. Altaris completed a $600M deal for Clarivate's healthcare business.
Clarivate's Henry Levy, President of Life Sciences & Healthcare, terminated employment. A separation agreement includes retention payments and benefits. Details were disclosed in an SEC filing.
Clarivate (NYSE: CLVT) completed the $600M sale of its Life Sciences & Healthcare segment to Altaris, simplifying its portfolio and focusing on Academia & Government and Intellectual Property segments. The company plans to use proceeds to reduce debt and strengthen its balance sheet, aiming to drive growth and shareholder value. Clarivate will update its full-year 2026 guidance on November 3, 2026.
Over the past 7 days, AlphAI's AI scored 8 news stories mentioning CLVT (CLARIVATE PLC). Coverage has skewed bullish: 4 bullish, 4 neutral, and 0 bearish.
Recent CLVT coverage spans corporate actions, mergers & acquisitions and financial news.
Clarivate’s life‑sciences unit is now owned by Altaris, removing it from the public company.
Executive departure may raise uncertainty about the Life Sciences & Healthcare segment.
The divestiture removes a revenue stream but provides cash to lower leverage, likely causing modest short‑term price pressure while improving long‑term balance‑sheet strength.
The tender offer completion may affect Clarivate's debt profile and liquidity but has limited immediate price impact.
The tender offer may lead to note redemptions and affect CLVT's credit profile and stock perception.
AlphAI scores every news story that mentions CLVT with an AI model for sentiment and relevance, and aggregates insider trades from CLARIVATE PLC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Wandercraft acquired Ekso Bionics to form a global medical exoskeleton company. Automation Anywhere agreed to buy Boost.ai for conversational AI. Beam Global will acquire ScoutDI for $24M to expand drone tech. Altaris completed a $600M deal for Clarivate's healthcare business.
2 min readClarivate's Henry Levy, President of Life Sciences & Healthcare, terminated employment. A separation agreement includes retention payments and benefits. Details were disclosed in an SEC filing.
1 min readClarivate (NYSE: CLVT) completed the $600M sale of its Life Sciences & Healthcare segment to Altaris, simplifying its portfolio and focusing on Academia & Government and Intellectual Property segments. The company plans to use proceeds to reduce debt and strengthen its balance sheet, aiming to drive growth and shareholder value. Clarivate will update its full-year 2026 guidance on November 3, 2026.
2 min readCLARIVATE PLC (CLVT) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Clarivate Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt Securities LONDON, September 24, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the expiration a
2 min readClarivate Plc (NYSE: CLVT) announced the pricing terms for its cash tender offer to purchase up to $75M of its 3.875% Senior Secured Notes due 2028, with a proration mechanism in place. The offer, managed by Citigroup, expires on September 23, 2026, with a settlement date expected on September 25, 2026.
2 min readCLARIVATE PLC (CLVT) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Clarivate Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt Securities LONDON, September 23, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the Reference Yi
2 min readClarivate Plc (NYSE: CLVT) announced it will release its Q3 2026 financial results on November 3, 2026, before market open. The company will host a conference call and webcast at 8:30 AM ET to discuss the results, with details available on its investor website.
1 min readClarivate Plc (NYSE: CLVT) announced a cash tender offer to purchase up to $75M of its 3.875% Senior Secured Notes due 2028. The offer, managed by Citigroup, expires on September 23, 2026, with a settlement date of September 25, 2026. The total consideration is based on a fixed spread and reference yield, with accrued interest also payable.
2 min readCLARIVATE PLC (CLVT) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities LONDON, September 17, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced that its wholly-owned subsidiary,
1 min readCornick Kenneth L. purchased 900,000 indirectly-held shares of CLARIVATE PLC (CLVT) at an average of $1.86 ($1.85–$1.86, $1.67M total) across 2 trades over 2026-08-06 to 2026-08-07.
1 min read
